Navigation Links
Prime Therapeutics Receives VIPPS Accreditation
Date:5/21/2008

ST. PAUL, Minn., May 21 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today that it has received accreditation from the National Association of Boards of Pharmacy(R) (NABP(R)) through its Verified Internet Pharmacy Practice Sites(TM) (VIPPS(R)) Program.

Prime has met the VIPPS standards established by NABP in response to consumers' concerns regarding the safety of pharmacy practices on the Internet. VIPPS accreditation further authenticates Prime's Web-based pharmacy services as a reputable, accredited source of prescription drugs. PrimeMail(R), Prime's mail-service pharmacy, uses the Internet as a safe and convenient way for members to place orders and provides access to a number of useful pharmacy tools.

"Prime's top priority is ensuring that clients and members are continually receiving the highest quality care and service," said Keith McFalls, Vice President of PrimeMail. "VIPPS accreditation further demonstrates Prime's commitment to providing unmatched member safety and satisfaction while empowering clients with tools and information to aid in making more informed health care management decisions."

To become VIPPS accredited, a pharmacy must comply with the licensing and inspection requirements in each state they dispense pharmaceuticals. In addition, pharmacies that are VIPPS accredited have demonstrated to NABP compliance with VIPPS criteria, including: patient rights to privacy, authentication and security of prescription orders, adherence to a recognized quality assurance policy, and provision of meaningful consultation between patients and pharmacists.

Prime began the VIPPS accreditation process in April 2007 and received official accreditation confirmation on March 5, 2008. Prime's Web services provide a wide range of pharmacy benefit information and protects member confidentiality with password protections, encryption, firewalls and secure links. Member Web sites also include useful tools such as drug research options that allow members to review specific drug information, a complete prescription history list and a cost calculator that offers side by side cost comparisons of brand-name and generic drugs at both PrimeMail and retail pharmacies.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing, innovative, clinically-based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 (legal) million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by ten Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Primera Biosystems Raises $21 Million in Series B Private Round
2. Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
3. ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
4. Cell Therapeutics, Inc. (CTI) to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Nile Therapeutics Reports 2008 First Quarter Financial Results
6. Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
7. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
8. Amicus Therapeutics Announces First Quarter 2008 Financial Results
9. Nile Therapeutics to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
10. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
11. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
Breaking Biology Technology:
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
Breaking Biology News(10 mins):